Washington Trust Advisors, Inc. Pulmonx Corp Transaction History
Washington Trust Advisors, Inc.
- $1.15 Billion
- Q4 2024
A detailed history of Washington Trust Advisors, Inc. transactions in Pulmonx Corp stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 167 shares of LUNG stock, worth $1,170. This represents 0.0% of its overall portfolio holdings.
Number of Shares
167
Previous 167
-0.0%
Holding current value
$1,170
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
30.6MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.51MShares$38.6 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.79MShares$26.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$18.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$16 Million0.0% of portfolio
-
Bnp Paribas Asset Management Holding S.A.1.25MShares$8.78 Million0.02% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $261M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...